These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11447075)

  • 1. Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes.
    Harada E; Yoshimura M; Yasue H; Nakagawa O; Nakagawa M; Harada M; Mizuno Y; Nakayama M; Shimasaki Y; Ito T; Nakamura S; Kuwahara K; Saito Y; Nakao K; Ogawa H
    Circulation; 2001 Jul; 104(2):137-9. PubMed ID: 11447075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes.
    Yamamuro M; Yoshimura M; Nakayama M; Abe K; Sumida H; Sugiyama S; Saito Y; Nakao K; Yasue H; Ogawa H
    Circ J; 2008 Aug; 72(8):1346-50. PubMed ID: 18654024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes.
    Wang J; Yu L; Solenberg PJ; Gelbert L; Geringer CD; Steinberg MI
    J Card Fail; 2002 Jun; 8(3):167-74. PubMed ID: 12140810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells.
    Sugiyama T; Yoshimoto T; Tsuchiya K; Gochou N; Hirono Y; Tateno T; Fukai N; Shichiri M; Hirata Y
    Endocrinology; 2005 Sep; 146(9):3900-6. PubMed ID: 15932931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac aldosterone production in genetically hypertensive rats.
    Takeda Y; Yoneda T; Demura M; Miyamori I; Mabuchi H
    Hypertension; 2000 Oct; 36(4):495-500. PubMed ID: 11040225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.
    Karram T; Abbasi A; Keidar S; Golomb E; Hochberg I; Winaver J; Hoffman A; Abassi Z
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1351-8. PubMed ID: 15894569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
    Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
    Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.
    Keidar S; Gamliel-Lazarovich A; Kaplan M; Pavlotzky E; Hamoud S; Hayek T; Karry R; Abassi Z
    Circ Res; 2005 Oct; 97(9):946-53. PubMed ID: 16179584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes.
    Ito T; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Yamamuro M; Harada M; Saito Y; Nakao K; Kurihara H; Yasue H; Ogawa H
    Circulation; 2003 Feb; 107(6):807-10. PubMed ID: 12591748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats.
    Zhang ZH; Yu Y; Kang YM; Wei SG; Felder RB
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H1067-74. PubMed ID: 18162560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ; Nakamura S; Ma L; Nakamura I; Donnert E; Freeman M; Vaughan DE; Fogo AB
    Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultured myofibroblasts generate angiotensin peptides de novo.
    Katwa LC; Campbell SE; Tyagi SC; Lee SJ; Cicila GT; Weber KT
    J Mol Cell Cardiol; 1997 May; 29(5):1375-86. PubMed ID: 9201623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C betaII activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes.
    Zhang Y; Bloem LJ; Yu L; Estridge TB; Iversen PW; McDonald CE; Schrementi JP; Wang X; Vlahos CJ; Wang J
    Cardiovasc Res; 2003 Jan; 57(1):139-46. PubMed ID: 12504823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.